CTNM vs CTVA · $429.6M cap vs P/E 42, rev $16.91B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus Corteva Inc (CTVA) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
CTNM currently screens at market cap $429.6M. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Not investment advice. Open the CTNM and CTVA stock pages for the full models.
Not investment advice.